How often it is a primary outcome
Picture Naming Test43% of 466 studies
Vocabulary Test37% of 199 studies
Token Commands Task33% of 36 studies
Lexical Decision Task32% of 22 studies
Serial Naming Task32% of 22 studies
Clinical trials data
Every registered study on ClinicalTrials.gov that names the Picture Naming Test in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.
Dementia and Alzheimer's104 studies, 38 as a primary outcome
Stroke99 studies, 56 as a primary outcome
Mild cognitive impairment71 studies, 23 as a primary outcome
Parkinson's disease37 studies, 7 as a primary outcome
Cognitive impairment and decline23 studies, 15 as a primary outcome
Aging, frailty and exercise23 studies, 9 as a primary outcome
Depression and bipolar disorder19 studies, 6 as a primary outcome
Brain injury and concussion15 studies, 7 as a primary outcome
Cancer14 studies, 8 as a primary outcome
Obesity and diabetes14 studies, 5 as a primary outcome
Cardiovascular disease14 studies, 4 as a primary outcome
Delirium, surgery and intensive care10 studies, 3 as a primary outcome
Sleep and sleep disorders8 studies, 2 as a primary outcome
Epilepsy8 studies, 3 as a primary outcome
Schizophrenia and psychosis7 studies, 3 as a primary outcome
COVID-19 and long COVID6 studies, 4 as a primary outcome
Anxiety, PTSD and OCD6 studies, 1 as a primary outcome
Healthy volunteers5 studies, 3 as a primary outcome
Autism3 studies, 2 as a primary outcome
Hearing loss3 studies, 2 as a primary outcome
Multiple sclerosis2 studies, 1 as a primary outcome
Substance use and addiction2 studies, 1 as a primary outcome
Pain and fatigue2 studies, 0 as a primary outcome
Other conditions73 studies, 37 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Picture Naming Test43% of 466 studies
Vocabulary Test37% of 199 studies
Token Commands Task33% of 36 studies
Lexical Decision Task32% of 22 studies
Serial Naming Task32% of 22 studies
A test as a primary outcomeOnly in secondary or other outcomes
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 2 | 2 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
| 2007 | 6 | 1 |
| 2008 | 6 | 3 |
| 2009 | 7 | 2 |
| 2010 | 4 | 2 |
| 2011 | 9 | 5 |
| 2012 | 13 | 6 |
| 2013 | 15 | 7 |
| 2014 | 13 | 4 |
| 2015 | 23 | 11 |
| 2016 | 18 | 10 |
| 2017 | 23 | 6 |
| 2018 | 22 | 14 |
| 2019 | 33 | 18 |
| 2020 | 30 | 18 |
| 2021 | 42 | 20 |
| 2022 | 37 | 13 |
| 2023 | 46 | 19 |
| 2024 | 37 | 15 |
| 2025 | 36 | 10 |
| 2026 | 36 | 11 |
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 42 | 43 | 24 to 108 |
| Not applicable | 300 | 48 | 22 to 93 |
| Observational | 78 | 153 | 80 to 623 |
A test as a primary outcomeOnly in secondary or other outcomes
441 of the 466 outcome measures give a duration. A single visit counts as within a day.
Intervention types as registered. A study can list several; observational studies often list none.
50 countries in all. A study with sites in several counts in each; 36 list no site.
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed studies that name the Picture Naming Test: 92 of 184, 50%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed studies that name the Picture Naming Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 18, 10% | 776, 10% |
| Results on ClinicalTrials.gov only | 36, 20% | 1,139, 14% |
| A results paper only | 38, 21% | 1,711, 22% |
| Neither | 92, 50% | 4,327, 54% |
Verbal Fluency206 studies, 79 as a primary outcome
Trail Making Test189 studies, 66 as a primary outcome
Verbal Learning180 studies, 73 as a primary outcome
Digit Span Test148 studies, 51 as a primary outcome
Category Fluency127 studies, 57 as a primary outcome
Stroop Color-Word Test97 studies, 35 as a primary outcome
Complex Figure Copy and Recall74 studies, 30 as a primary outcome
Clock Drawing Task70 studies, 26 as a primary outcome
Short Story Recall65 studies, 29 as a primary outcome
Symbol Coding61 studies, 30 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.
| Start year | Picture Naming Test | Verbal Fluency | Trail Making Test | Verbal Learning |
|---|---|---|---|---|
| 2000 | 0 | 1 | 2 | 1 |
| 2001 | 0 | 1 | 0 | 5 |
| 2002 | 1 | 3 | 3 | 8 |
| 2003 | 1 | 4 | 8 | 14 |
| 2004 | 2 | 9 | 10 | 14 |
| 2005 | 2 | 19 | 14 | 17 |
| 2006 | 1 | 9 | 14 | 13 |
| 2007 | 6 | 22 | 21 | 22 |
| 2008 | 6 | 18 | 17 | 28 |
| 2009 | 7 | 29 | 29 | 28 |
| 2010 | 4 | 29 | 32 | 42 |
| 2011 | 9 | 36 | 47 | 33 |
| 2012 | 13 | 34 | 44 | 42 |
| 2013 | 15 | 58 | 60 | 53 |
| 2014 | 13 | 59 | 66 | 82 |
| 2015 | 23 | 79 | 85 | 91 |
| 2016 | 18 | 85 | 103 | 98 |
| 2017 | 23 | 93 | 122 | 107 |
| 2018 | 22 | 107 | 117 | 92 |
| 2019 | 33 | 121 | 155 | 122 |
| 2020 | 30 | 90 | 122 | 76 |
| 2021 | 42 | 131 | 172 | 137 |
| 2022 | 37 | 123 | 188 | 138 |
| 2023 | 46 | 147 | 228 | 157 |
| 2024 | 37 | 130 | 211 | 144 |
| 2025 | 36 | 167 | 210 | 132 |
| 2026 | 36 | 133 | 201 | 123 |
466 studies match. 201 name the Picture Naming Test in a primary outcome. Median size 60 participants. Median time to the primary outcome: 13 weeks.
Loading 466 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 3 planned to start after 2026.
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 2 | 2 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
| 2007 | 6 | 1 |
| 2008 | 6 | 3 |
| 2009 | 7 | 2 |
| 2010 | 4 | 2 |
| 2011 | 9 | 5 |
| 2012 | 13 | 6 |
| 2013 | 15 | 7 |
| 2014 | 13 | 4 |
| 2015 | 23 | 11 |
| 2016 | 18 | 10 |
| 2017 | 23 | 6 |
| 2018 | 22 | 14 |
| 2019 | 33 | 18 |
| 2020 | 30 | 18 |
| 2021 | 42 | 20 |
| 2022 | 37 | 13 |
| 2023 | 46 | 19 |
| 2024 | 37 | 15 |
| 2025 | 36 | 10 |
| 2026 | 36 | 11 |
Lead sponsor: industry 28, other 438. Interventional 388, observational 78.
As a primary outcomeSecondary or other outcomeThe Picture Naming Test
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07813156 | Start2026 | PhaseNot applicable | ConditionsParkinson's disease | Participants24 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07772765 | Start2026 | PhaseNot applicable | ConditionsOther conditions | Participants216 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07759375 | Start2027 | PhaseNot applicable | ConditionsStroke | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07753382 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants36 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07734675 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis | Participants130 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07726654 | Start2026 | PhaseObservational | ConditionsOther conditions | Participants400 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07722169 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07692399 | Start2026 | PhasePhase 2 | ConditionsOther conditions | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07688382 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07673198 | Start2026 | PhaseNot applicable | ConditionsOther conditions | Participants12 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07652476 | Start2026 | PhaseObservational | ConditionsCancer | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07650318 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07642518 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07638813 | Start2026 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants33 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07628686 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants120 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07608588 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07608510 | Start2026 | PhaseObservational | ConditionsMild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07580183 | Start2024 | PhaseNot applicable | ConditionsDelirium, surgery and intensive care, Epilepsy | Participants620 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07547800 | Start2026 | PhaseNot applicable | ConditionsStroke, Healthy volunteers | Participants109 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07540325 | Start2026 | PhaseObservational | ConditionsParkinson's disease | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07519317 | Start2027 | PhaseNot applicable | ConditionsStroke | Participants90 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07517380 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07515261 | Start2023 | PhaseNot applicable | ConditionsAutism | Participants22 | Lead sponsorOther | StatusCompleted | Library tests named
|
466 registered studies on ClinicalTrials.gov name it in an outcome measure, 201 of them in a primary outcome.
Most often in dementia and Alzheimer's disease (104), stroke (99) and mild cognitive impairment (71).
2.8% of the studies that started in 2021 to 2025 name it, against 2.8% of those that started in 2016 to 2020: about the same share.
Verbal Fluency (206 studies), the Trail Making Test (189 studies) and Verbal Learning (180 studies).
Half of the phase 2 studies that name it enroll 43 participants or fewer, and the middle half enroll 24 to 108. 42 of them give a size.
Half of the primary outcomes that name the Picture Naming Test are measured within 13 weeks of the start, and the middle half from 4 weeks to 6 months. 189 primary outcomes give a duration.
92 of the 184 completed studies that name it, 50%, have reported results: 54 posted them on ClinicalTrials.gov, 56 have a results paper linked to the registry record, and 18 did both. The other 92 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.